Kotaro Suzuki

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Metastatic Renal Cell Carcinoma

Cardiac Surgery

Top Venues

International journal of clinical oncology

International journal of urology : official journal of the Japanese Urological Association

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Hideto Ueki, Naoe Jimbo, Tomoaki Terakawa, Takuto Hara, Taisuke Tobe, Junichiro Hirata, Naoto Wakita, Yasuyoshi Okamura, Kotaro Suzuki, Yukari Bando, Koji Chiba, Jun Teishima, Yuzo Nakano, Hideaki Miyake
Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53. The Prostate (2024)
Takuto Hara, Kotaro Suzuki, Keisuke Okada, Koji Chiba, Jun Teishima, Hideaki Miyake
Comparative clinical trials with a novel approach: Utilizing the shiny method for investigational urothelial carcinoma therapies. International journal of urology : official journal of the Japanese Urological Association (2024)
Kotaro Suzuki, Yasuyoshi Okamura, Yukari Bando, Takuto Hara, Keisuke Okada, Tomoaki Terakawa, Yoji Hyodo, Koji Chiba, Jun Teishima, Yuzo Nakano, Hideaki Miyake
Adrenalectomy for pheochromocytoma: Surgical outcomes and preoperative risk factors for hemodynamic instability. International journal of urology : official journal of the Japanese Urological Association (2024)
Kotaro Suzuki, Yasuyoshi Okamura, Takuto Hara, Tomoaki Terakawa, Junya Furukawa, Kenichi Harada, Nobuyuki Hinata, Masato Fujisawa
Prognostic impact of bone metastatic volume beyond vertebrae and pelvis in patients with metastatic hormone-sensitive prostate cancer. International journal of clinical oncology 26 (8) (2021)
Kotaro Suzuki, Takuto Hara, Tomoaki Terakawa, Kenichi Harada, Masato Fujisawa
Efficacy of axitinib rechallenge in metastatic renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association 28 (6) (2021)
Kotaro Suzuki, Tomoaki Terakawa, Junya Furukawa, Kenichi Harada, Nobuyuki Hinata, Yuzo Nakano, Masato Fujisawa
Clinical outcomes of second-line treatment following prior targeted therapy in patients with metastatic renal cell carcinoma: a comparison of axitinib and nivolumab. International journal of clinical oncology 25 (9) (2020)
Kotaro Suzuki, Tomoaki Terakawa, Junya Furukawa, Kenichi Harada, Nobuyuki Hinata, Yuzo Nakano, Masato Fujisawa
C-reactive protein and the neutrophil-to-lymphocyte ratio are prognostic biomarkers in metastatic renal cell carcinoma patients treated with nivolumab. International journal of clinical oncology 25 (1) (2019)
Kotaro Suzuki, Michiyo Koyanagi-Aoi, Keiichiro Uehara, Nobuyuki Hinata, Masato Fujisawa, Takashi Aoi
Directed differentiation of human induced pluripotent stem cells into mature stratified bladder urothelium. Scientific reports 9 (1) (2019)